Significance of peritoneal washing cytology as a predictive factor for the long-term benefit of secondary debulking surgery in ovarian cancer
Journal of Gynecologic Oncology · 2026
DOI: 10.3802/jgo.2026.37.e94 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gynecologic Oncology, 2026. Verfasst von Hiroaki Nagano und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Tokyo Women's Medical University School of Medicine, Adachi Medical Center, Tokyo, Japan. nagano.hiroaki@twm…. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Cytoreduction Surgical Procedures, Peritoneal Lavage, Peritoneal Neoplasms. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
OBJECTIVE: This study aimed to evaluate the significance of peritoneal washing cytology (PWC) as a predictive factor of the long-term benefits of secondary debulking surgery (SDS) for ovarian cancer (OC). METHODS: We retrospectively reviewed the clinical records of patients with OC who underwent SDS for intraperitoneal recurrence (IPR). Various clinical data points were investigated, including the residual tumor size at SDS, PWC results at SDS, progression-free survival (PFS), and overall survival (OS). RESULTS: Between 2007 and 2022, 207 patients with ovarian, fallopian, or peritoneal cancers were treated at our institution. IPR occurred in 49 patients, 20 of whom underwent SDS. This study included 18 patients, excluding 2 patients with squamous cell carcinoma. Complete resection of the SDS was achieved in 15 patients. PWC was negative in 12 patients but positive in 6; ascites was not observed in any patient. IPR occurred in all PWC-positive patients after SDS, although 3 patients had no residual tumors. In contrast, only 4 of the 12 PWC-negative patients (all without residual tumors) experienced IPR during follow-up (median: 78 months), 2 of whom had secondary IPR at SDS. The association between PWC and IPR after SDS was significant (p=0.009, Fisher's exact test). The PFS and OS after SDS were significantly higher in the PWC-negative group than in the PWC-positive group. CONCLUSION: PWC is a significant predictor of the long-term benefit of SDS in patients with OC and IPR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Tokyo Women's Medical University School of Medicine, Adachi Medical Center, Tokyo, Japan. nagano.hiroaki@twmu.ac.jp.
- Department of Obstetrics and Gynecology, Tokyo Women's Medical University School of Medicine, Adachi Medical Center, Tokyo, Japan.
ORCID-Profile: Hiroaki Nagano, Akimasa Ichinoe
Zitieren
APA
Nagano, H., & Ichinoe, A. (2026). Significance of peritoneal washing cytology as a predictive factor for the long-term benefit of secondary debulking surgery in ovarian cancer. Journal of Gynecologic Oncology. https://doi.org/10.3802/jgo.2026.37.e94
Vancouver
Nagano H, Ichinoe A. Significance of peritoneal washing cytology as a predictive factor for the long-term benefit of secondary debulking surgery in ovarian cancer. Journal of Gynecologic Oncology. 2026. doi:10.3802/jgo.2026.37.e94
BibTeX
@article{Nagano2026,
author = {Nagano, Hiroaki and Ichinoe, Akimasa},
title = {Significance of peritoneal washing cytology as a predictive factor for the long-term benefit of secondary debulking surgery in ovarian cancer},
journal = {Journal of Gynecologic Oncology},
year = {2026},
doi = {10.3802/jgo.2026.37.e94}
}
EUVIMED